Navigation Links
A New Drug That Could Revolutionize Management Of Heart Disease

In a study published in the Journal of Clinical Investigation and the September issue of Nature Reviews/Drug Discovery//, researchers at Monash University have reported that a new drug helps in reducing the risk of high blood pressure and heart attacks by improving the blood flow in diseased arteries. The new drug developed by Bayer HealthCare was found to reactivate a key enzyme, damaged by free radicals, which helps in dilatation of the arteries.

The finding is a significant development for the Monash team that, in conjunction with Bayer Health Care, hopes to use the drug as part of a revolution in the management of heart disease.

Dr. Harald Schmidt, Director of the Centre for Vascular Health and his colleagues at Monash University, Dr. Peter Schmidt and Barbara Kemp-Harper, say the next step will be to translate the research so it benefits patients. Clinical trials of the drug have already started for the treatment of acute heart failure.

Dr. Schmidt's team and colleagues in Germany and the US have previously shown that oxidative stress - the appearance of free radicals in the walls of arteries - is a key mechanism underlying cardiovascular disease.

"Free radicals contribute to the formation of arterial blockages. What's more, as the number of free radicals increases, they also interfere with the ability of the cells lining arteries to control the contraction and dilation of the arteries," Dr. Schmidt says. "The arteries stiffen and get blocked."

When a blockage occurs, the cells lining the arteries produce nitric oxide to signal to the arterial muscles that they need to dilate the artery and allow more blood through. But free radicals destroy a key enzyme that allows the arterial cells to respond in this way, so the signal doesn't get through.

However, the new drug – developed by Bayer HealthCare – reactivates the damaged enzyme.

"Our results show that the drug directly binds to
'"/>




Page: 1 2

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Nasal Spray Could Take Drugs Direct to Brain.
3. Nasal Spray Could Take Drugs Directly to Brain
4. Oxygen Usage During Exercise Could Indicate Heart Problems
5. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
6. Anger Could Be Linked To Weight Gain
7. A Seizure Late In Life Could be A Stroke Warning
8. New Findings Could Reduce The Extent Of Spinal Cord Injuries
9. Could There Be A Link Between Famine and Breast Cancer ?
10. Bone Marrow Cells Could Yield A New Lease of Life
11. New Hair in 15 Days Could Now Be A Possibility Say Researchers
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...n the brains of vertebrates and fruit fly denote w... these visual maps// that need to be wired properl...lt stage. A general notion is that visual maps are...genetically programmed but needs neurons or nerve ...
...ecalling its dietary supplementary product after t...is an analogue of sildenafil, the active pharmaceu... the treatment of erectile dysfunction and it is e... action. This is an unwanted effect in the drug. ...
...Dairy, South of Fresno, is going through a rough p... products.// The ban was enforced after three chil... E.Coli contamination. The dairy owner refuting th...f confusion. The actual notice they gave us is ful...
...people die of coronary diseases in India annually ... next 10 years due to loss in productive working d...y India is home to over 60 million coronary heart ...ients are succumbing to the disease every year," w...
Other Medicine News:Health News:Fruit fly’s visual map based entirely on genetic inputs 2Health News:India may Lose Over $230 bn from Heart Diseases 2
(Date:9/4/2008).... 4 /- Southern Research Institute,to...th (NIH) has selected,the organization to particip...Production Center Network (MLPCN). The MLPCN -- a ...olecular Libraries Program which is,designed to be...f the human,genome and validate future targets for...
(Date:9/4/2008)...es potent antiviral activity and favorable safety ...E, Mass., Sept. 4 /- Idenix...maceutical company engaged,in the discovery and de...l,and other infectious diseases, today announced t...aluating IDX899, a non-nucleoside reverse,transcri...
(Date:9/3/2008)...n Asked. Wrong Children Studied. Wrong,Conclusions...ire/ -- A Centers for Disease,Control and Preventi...ink,between the MMR vaccine and autism. The Nation...othing to dispel the growing public concern over a...tions concerning design,and methodology., For yea...
(Date:9/3/2008)...tional Vascular Disease Awareness Month, CHARLOTT...armaceuticals,LLC, a clinical-stage drug-developme...ment of unmet medical needs, announced today that ...inical trial of its lead drug,candidate trans sodi...25881,on the clinicaltrials.gov Website, is invest...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Amsterdam Native and St Jude Patient Christian Gizara to Appear With Marlo Thomas on Dec 8 Larry King Live to Educate Viewers About Life Saving Work 7321 1Amsterdam Native and St Jude Patient Christian Gizara to Appear With Marlo Thomas on Dec 8 Larry King Live to Educate Viewers About Life Saving Work 7321 2Amsterdam Native and St Jude Patient Christian Gizara to Appear With Marlo Thomas on Dec 8 Larry King Live to Educate Viewers About Life Saving Work 7321 3Pelosi Statement on World AIDS Day 7317 1Pelosi Statement on World AIDS Day 7317 2Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 7313 1Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 7313 2Groups Call On Senator Charles Schumer to Lead Senate In Strengthening Medicare 7313 3AIDS Healthcare Foundations Role in the City of Los Angeles HIV Testing Initiative 7309 1AIDS Healthcare Foundations Role in the City of Los Angeles HIV Testing Initiative 7309 2
...2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc. ...ical trial of GVAX immunotherapy,for pancreatic ca...ey Kimmel Cancer Center. The trial enrolled 60 pat... GVAX after surgical,resection of their tumor and ... overall survival for these patients was previousl...
...07 – Data presented,today at this year&rsquo...eting in Chicago show that a novel combination reg...il (5-FU) therapy UFT,(tegafur–uracil) plus ...te in the first-line treatment of metastatic color...f CPT-11 with Oxaliplatin combined,with UFT plus l...
Other Medicine Technology:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 2Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 3Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 4Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 5Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 2Merck at ASCO 2007: New Data Demonstrate the Value of UFT as an,Important Treatment Option for Patients With Metastatic Colorectal,Cancer 3
...dular peltier refrigeration system that can be add...xe bath system as standard which provides for grea...n orientation. The unit will chill the Vibratome ...ent temperature. It will maintain bath temperatur...
The glass knife adapter allows for the use of glass knives or ralph knives on the Vibratome. The adapter can be installed in place of the standard razor blade mounting device.
Inquire
Inquire
Medicine Products: